Next Generation Digital Natural History Study

What is a Natural History Study and Why Do they Matter?
Natural History Studies (NHS) are critical to the drug development process. Ciitizen has developed a new method to make this process easier. A next generation, digital NHS for CHD2-related disorders is expected to facilitate:
-
Informing clinical researchers how a disease changes over time
-
Enabling better endpoint selection to use in clinical trials
-
Understanding the connection between mutation types and symptoms
-
Reducing the time it takes to study new medicines in clinical trials
-
Speeding up the time to get therapeutics to patients
-
Using data as a placebo (instead of actual patients) in a clinical trial
How it Works
-
Participation is completely digital - No clinic visits required
-
Collects participant's medical records from the institutions visited
-
Data from medical records is organized and summarized, free of charge to the participant
-
Participants retain full control of their health records
-
With your consent, clinicians, researchers and biopharma can access anonymized data to aid in research
-
Available now in the US with plans for worldwide availability
-
Registering with Ciitizen requires less than 10 minutes of your time